NE BioGroup to Distribute Nonlinear's TotalLab Range
News Mar 01, 2006
Under the contract, NE BioGroup, will distribute Nonlinear’s TotalLab product range for analysis of 1D electrophoresis gels, throughout the US.
Nonlinear’s extended TotalLab range incorporates the TL100 general image analysis software and TL120 for comprehensive, automated analysis of 1D gel images.
Also included is the TL120 DM analysis solution, incorporating an enhanced database component to enable researchers to store and mine data across multiple experiments. All software will be available for both PC and Apple Mac users.
Lou Farrell, CEO of New England BioGroup, LLC, said, "We work very closely with our customers to ensure they have the best tools to advance their research and accelerate discovery."
"As such, the quality of Nonlinear’s TotalLab range makes it an extremely significant addition to our product portfolio. We are confident that life science researchers located in New England and the rest of the U.S. will benefit considerably through this agreement."
John Spreadbury, Group Sales and Marketing Director at Nonlinear Dynamics and CEO of Nonlinear USA Inc., said, "Continually evolving, the extended TotalLab range provides user-centric solutions."
"It is scientifically tailored to combine outstanding usability with incisive automated analysis features to benefit users, delivering a choice of products customisable to their level of research."
"The TotalLab software fully compliments NE BioGroup’s established portfolio of first-dimensional electrophoresis instrumentation and consumables."
"This factor, coupled with NE BioGroup’s excellent reputation in the US life sciences market made them a natural partner; we are delighted to be working with them."
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE